Generics 43

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Bacitracin manufacturers

43 products found

Filters

43 products found

bacitracin + polymyxin b sulfate + hydrocortisone acetate

Cutaneous ointment 5 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16182
It is a family-owned company based in Western Europe that specializes in the production of pediatric pharmaceuticals. All of the medicines give the added value that patients, physicians, and pharmacists have grown to expect from the company over the past 30 years as a top pediatric pharmaceutical company in the country. More than 130 products are available in the portfolio for a wide range of indications in dermatology, allergology, respiratory disorders, and ENT.

Manufacturer usually replies in 7 days

bacitracin + neomycin

Cutaneous spray (1338,22 + 103,80) UI/G

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Kosovo
Available for
Licensing with supply
Manufacturer #15932

A pharmaceutical manufacturer based in the EU that is active in 20+ countries for 20+ years. Key production lines are generic, medical device, OTC, nutraceuticals, and cosmetics. They are produced in GMP-compliant manufacture. Main therapeutic areas include allergology and pulmonology, cardiology, dermatology, and the central nervous system. The main dosage forms are liquid, solid, semi-solid, and sprays.

Manufacturer usually replies in 11 days

bacitracin

Cutaneous ointment 0.9 g

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #19623

Manufacturer usually replies in 10 days

bacitracin + neomycin + polymyxin b

Cutaneous ointment 400IU+3,5mg+5000IU

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #19576

Manufacturer usually replies in 13 days

bacitracin

Cutaneous ointment TBD

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #3263

Manufacturer usually replies in 10 days

bacitracin

Cutaneous ointment 500 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #17256

Manufacturer usually replies in 2 days

bacitracin + neomycin sulfate + polymyxin b sulfate

Cream 400 units + 5mg + 5,000 units

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, WHO
Manufacturer #13266

Manufacturer usually replies in 2 days

bacitracin + polymyxin b sulfate + neomycin sulfate

Cutaneous ointment 400 units + 5000 units + 3400 units - 30 gm

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17256

Manufacturer usually replies in 2 days

bacitracin

Cutaneous ointment 500 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19657

Manufacturer usually replies in 10 days

bacitracin + neomycin sulfate

Cutaneous ointment 500 IU + 5 mg / g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Peru
GMP approvals
WHO
Manufacturer #18809

Manufacturer usually replies in 7 days

bacitracin + neomycin sulfate + polymyxin b sulfate

Cutaneous ointment 40,000 IU + 325 mg + 500,000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Peru
GMP approvals
WHO
Manufacturer #18809

Manufacturer usually replies in 7 days

bacitracin + polymyxin b sulfate

Cream 500 IU + 10 000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
WHO
Manufacturer #17854

Manufacturer usually replies in 8 days

bacitracin + polymyxin b

Cutaneous ointment TBD

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
Israel
Manufacturer #414

bacitracin + neomycin + polymyxin b

Cream X

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
Israel
Manufacturer #414

bacitracin + polymyxin b sulfate

Ointment 500 IU/g + 1000 IU/g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
United Arab Emirates
GMP approvals
Canada
Manufacturer #31061

bacitracin + gramicidin + polymyxin b sulfate

Ointment 500 IU + 0.25 mg + 1000 IU/g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
United Arab Emirates
GMP approvals
Canada
Manufacturer #31061

bacitracin

Ointment 500 IU - 30 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #28191

Manufacturer usually replies in nan days

neomycin sulfate + bacitracin + polymyxin b sulfate

Cutaneous ointment 5mg + 10mg + 0.833 mg / 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17355
It is a privately held pharmaceutical company that has been in business for more than 70 years. Initially, the company's major source of revenue was the manufacture and services of diverse profiles, with pharmaceutical production accounting for only a small portion of its operations. Pharmaceutical production was already the Cooperative's main activity in the 1990s. So it has been till now. Over 90 different products are available from the company, primarily for dentists and dermatologists.

Manufacturer usually replies in 7 days

neomycin sulfate + bacitracin

Ointment 5000 IU + 250 IU/g - 20 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Reference product: Baneocin, Sandoz File status: EU eCTD Hybrid application Q3 2024
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 20 days

neomycin + bacitracin

Cutaneous ointment 3300 IU/g + 250 IU/g, 500 IU/g + 2000 IU/g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #688
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, Middle East, and Asia for 50+ years. Main therapeutic areas include cardiovascular, anti-infectives, and skin disorders. The main dosage forms are semi-solid and liquid forms. They are produced in GMP-compliant manufacture. Regularity team prepares EU CTD format document.

Manufacturer usually replies in 16 days

Want to view all 43 products? Create your free account today!

Bacitracin is an antibiotic used to treat pneumonia as well as local skin infections. Although manufacturers of bacitracin acetonide produce medications with it as the standalone ingredient its more frequent use is in combination formulations along with ingredients, most notable of which are neomycin and polymyxin B. Bacitracin suppliers market it in a wide range of forms, such as powders for injectable solutions, topical ointments, topical creams, topical powders, and ophthalmic ointments. Bacitracin suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified bacitracin manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Bacitracin is a low-cost medication. Retail prices for 10g of bacitracin topical powder fall into an approximate range of 4,00 EUR to 5,00 EUR, whereas 20g of topical cream can cost from 4,00 EUR to 6,00 EUR.